MedTrace Logo

Sedative Premedication in Coronary Angiography

NCT03576456 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 264

Last updated 2018-10-12

No results posted yet for this study

Summary

Evaluation of the possible positive effect of sedative premedication prior to coronary angiography in regards to pain and anxiety.

Conditions

  • Coronary Angiography
  • Sedative Premedication

Interventions

DRUG

Alprazolam 0.5 mg

receive alprazolam prior to angio

DRUG

Placebo Oral Tablet

receive placebo prior to angio

Sponsors & Collaborators

  • Universitair Ziekenhuis Brussel

    lead OTHER

Principal Investigators

  • Danny Schoors, MD PhD · Head of service

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-01-01
Completion
2020-08-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03576456 on ClinicalTrials.gov